Executive Board


The IANPHI Executive Board provides policy oversight to respected leaders of national public health institutes from around the world. The 14-member board includes the president, the vice president, the immediate past president and the directors of 11 member institutes.

Duncan Selbie

President, IANPHI
Former Chief Executive, Public Health England

Prof. Duncan Selbie was the founding chief executive of Public Health England (PHE) from 2013 to 2020. He has been an Executive Board member of IANPHI since 2016 and has also served as IANPHI Foundation Board trustee and IANPHI treasurer. 

Prior to 2013, he was chief executive of Brighton and Sussex University Hospitals, the regional teaching hospital for the south east of England. From 2003 to 2007 he was the director general of Programmes and Performance for the NHS, and subsequently its first director general of Commissioning. Prior to this, he was chief executive of South East London Strategic Health Authority, and before that, chief executive of the South West London and St George’s Mental Health NHS Trust.  

Other appointments include honorary professor at the Robert Gordon University, Aberdeen; honorary professor at Chester University, vice President of the College of Medicine, London; companion of the Institute of Healthcare Management; honorary fellow of the UK Faculty of Public Health; and board member of the Saudi Center for Disease Prevention and Control.

Duncan Selbie

Meerjady Flora

Vice President, IANPHI
Former Director General, Institute of Epidemiology, Disease Control & Research (IEDCR) & National Influenza Center (NIC), Bangladesh 

Dr. Meerjady Sabrina Flora, MBBS, MPH, PhD FAIMER fellow, is the director of the Institute of Epidemiology, Disease Control and Research (IEDCR), which is the nation's focal point for conducting disease surveillance, outbreak investigation, and research training. In 2007, the institute was nominated a National Influenza Centre (NIC) by the World Health Organization. 

Meerjady Flora

André van der Zande

Immediate Past President, IANPHI
Former Director General, National Institute for Public Health & the Environment (RIVM), The Netherlands

André van der Zande is the former director-general of the Dutch National Institute for Public Health & the Environment (RIVM). He was elected president of IANPHI in November 2018 after serving as vice president of the member organization focused on creating, strengthening and transforming public health institutes around the world. He studied biology at Leiden University and graduated with distinction in 1976. In 1984 he was awarded his Ph.D. from the same university on the subject of the field of tension between recreation and bird conservation.

From 1986 onwards he managed various large knowledge institutes in Wageningen, among them Alterra. He was a part-time professor of Spatial Planning and Cultural History under the Belvedère programme at Wageningen University (2005-2009).

In 2002 André Van der Zande made the changeover to the former Dutch Ministry of Agriculture, Nature and Food Quality (Ministerie van Landbouw, Natuur en Voedselkwaliteit, LNV). Until 2007 he was director-general at the LNV, and his responsibilities included agricultural policy, nature and biodiversity, manure policy and general environmental policy. In 2007 he became secretary-general there, until the merger of the LNV with the Dutch Ministry of Economic Affairs.

André van der Zande

Martha Lucia Ospina

Director, National Institute of Health, Colombia

Dr. Martha Lucia Ospina, from Cali, took office as director of the National Institute of Health (INS) in May 2016. Dr. Ospina is the first woman to officially lead the institute in its 103-year history.

Alumnus of the Faculty of Medicine of the Universidad Javeriana, specializing in Public Health Management and holding a master’s degree in epidemiology at the University of Valle and in economics at the Pompeu Fabra University, Barcelona (Spain), Martha Ospina has more than 20 years of experience in the health sector.

Before appointment to the INS where she spent six months as acting director, she was acting deputy minister and national director of Epidemiology and Demography at the Ministry of Health, director of the High Cost Disease Account, and director of Planning and Promotion and Health Maintenance of Social Security in Valle del Cauca, among other positions.

Martha Ospina is now before an entity that was founded more than a century ago and has shown great adaptability. Created in January 1917, the INS is responsible for monitoring, both in the territories and in the laboratory, events likely to impact public health. In fact, the quality and transparency of information from its surveillance system have made it a key center for research in Zika worldwide.

Among other responsibilities, the INS includes research and analysis of information for the definition of policies by the ministry and the production of antivenoms–snakebites, anti-scorpion and antilonomia–which no longer arouse interest in the big pharmaceutical houses.

The challenge of the new director will be to project the INS into its second century. This means, among other things, to make it a governing body, capable of generating networks and better management in research in the country.

Martha Lucia Ospina

George Fu Gao

Director, Chinese Center for Disease Control and Prevention

Professor George F. Gao is a member NPHI director and an IANPHI executive board member. He is the director of the Chinese Center for Disease Control and Prevention and the professor and director in CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, vice-president of Beijing Institutes of Life Science, the Chinese Academy of Sciences, and vice-president of the Chinese Society of Biotechnology.

Gao obtained his Ph.D (DPhil) degree from Oxford University, UK and did his postdoc work in both Oxford University and Harvard University (with a brief stay in Calgary University). His research interests include the molecular mechanism of interspecies transmission of pathogens, molecular virology and molecular immunology. His group research is now focusing on the influenza virus, Streptococcus suis and the molecular/structural basis of recognition of T cell receptors to peptide-MHC complexes.

He has published more than 500 refereed papers, 10 books or book chapters and has applied for 25 UK, US and Chinese patents.

George Fu Gao

Ebba Abate, PhD

Director, Ethiopian Public Health Institute

Dr. Ebba Abate leads the Ethiopian Public Health Institute (EPHI) by appointment of the Prime Minister of Ethiopia. Together with his team he is working in restructuring EPHI with the aim the institute to play additional roles in the health system in Ethiopia. EPHI has a staff of more than 1,000, undertaking over 60 projects per year in different areas. In addition, the institute is responsible to coordinate and enhance the National Clinical Laboratory services and the Public Health Emergency activities in Ethiopia.

Dr. Abate is a biomedical researcher who has got his PhD degree in Medical Microbiology (Immunology stream) in June 2013 from Linkoping University, Sweden. He worked at the University of Gondar for close to 20 years and serving the University at different positions. His contribution for the launching of different MSc and PhD studies and also his role during the establishment of the Tropical and Infectious Diseases Research Center at the University of Gondar was significant. He served as the first director of this research center until he joined the Ethiopian Public Health Institute in February 2017.

Dr. Abate has produced more than 45 publications in peer-reviewed journals together with his colleagues. He presented his work in more than 40 local and international scientific forums. He recently won an international award from People to People based in the U.S. for his contribution and leadership in the COVID-19 response in Ethiopia. Dr. Abate won also the Tore-Godal prize given on yearly basis for three outstanding young researchers in Ethiopia for the pioneering work of genotyping and identifying the prevailing HPV types, the etiologic agents of cervical cancer, for the first time in Ethiopia and the Sudan. He received the prize from the then Minister of Health of Ethiopia and current director of WHO, Dr. Tedros Adhanom. In addition to this award, Dr. Abate has received different awards (Gold medal, best student award, best researcher award and certificates of recognitions) from the University of Gondar, Jimma University and the University of Khartoum, Sudan and others. He has got several research grants from WHO, EDCTP, Swedish Research counsel, Heart and Lung Foundation, University of Gondar, AHRI, SIDA/SAREC, etc.

Ebba Abate

Lothar H. Wieler

President, Robert Koch Institute, Germany

Prof. Lothar H. Wieler is the president of the Robert Koch Institute in Berlin, the national public health institute in Germany. 

His research focusses on zoonotic diseases in a One health concept, i.e. infections that are passed between animals and humans, and account for many of the newly (re-)emerging infectious diseases. A particular research interest of Prof. Wieler are the molecular mechanisms, which enable bacterial zoonotic pathogens such as e. coli and s. aureus to infect different hosts, and develop resistance to antibiotics. In his work, Wieler has used genome-based typing methods to identify zoonotic pathogens, which were subsequently analyzed in functional experiments in order to learn more about their evolution and adaption to different habitats. The insights generated from this work can be used to develop new interventions to target pathogenic bacteria.

Wieler published more than 250 scientific publications and was awarded several scientific prices. He is co-founder of the German national research platform on zoonoses, and deputy spokesperson for the research consortium InfectControl 2020, which pursues intersectoral approaches to preventing and treating infections from a One Health perspective. Within InfectControl 2020, Wieler also heads the IRMRESS and Neobiom networks. IRMRESS researches innovative strategies to fight mult-drug resistant bacteria and aims to use next generation sequencing techniques to establish a molecular surveillance system. Neobiom identifies factors that change the microbiome, resistome and mykobiome of premature babies. Prof. Wieler is also a member of the Strategic and Technical Advisory Group for Infectious Hazards (STAG-IH) of the World Health Organisation, the scientific advisory board of the Global Research Collaboration for Infectious Disease Preparedness (GloPID-R) and the WHO Europe Advisory Committee on Health Research (EACHR). Since 2010, he is also an elected member of the German National Academy of Sciences, where he also holds the position of a senator. As an honorary professor with teaching responsibility, he continues to be associated with the Institute of Microbiology and Epizootics at the Department of Veterinary Medicine at Freie Universität Berlin.

Lothar H. Wieler

Juan Rivera

Director, National Institute of Public Health, Mexico

Juan Rivera Dommarco is a member NPHI director and a IANPHI Executive Board member. He is the newly appointed director of Mexico's National Institutes of Public Health, where he has been since 1993. There he founded the Center for Research in Nutrition and Health in 2001.

He is also professor of Nutrition in the School of Public Health of Mexico and adjunct professor at Emory University. Dr. Rivera has published more than 400 scientific articles, book chapters, and books, and made more than 500 presentations and conferences at scientific events. He is past recipient of the Kellogg International Nutrition Research Award from ASN, granted for active engagement in research to benefit populations in nonindustrialized countries, as demonstrated through publications in the scientific literature, and actively engaged in training new scientists for international nutrition research.

Juan Rivera

Camilla Stoltenberg

Director General, Norwegian Institute of Public Health

Camilla Stoltenberg is a medical doctor with a PhD in epidemiology. She was appointed director general of the Norwegian Institute of Public Health (NIPH) in 2012. NIPH is the public national expert and knowledge provider in infectious disease prevention, environmental medicine, mental health, epidemiology, non-communicable diseases, global health and forensic medicine. From 2002 to 2007, she served as director of the Division of Epidemiology, and from 2007 to 2012 as deputy director general of the NIPH with particular responsibility for strategic development of national health registries, cohorts, and biobanks.

Stoltenberg is a member of the WHO Technical Steering Committee for MNCA (Maternal, Newborn, Child and Adolescent Health), the EAT advisory board, the Reference Group for the Palestinian National Institute of Public Health, and the Scientific Oversight Group at the Institute of Health Metrics and Evaluation, University of Washington. Previous appointments include research evaluation committees at the Wellcome Trust, and several evaluation/funding and advisory committees in England/UK, France, Germany, Sweden and Denmark.  

Her current scientific work focuses on neurodevelopmental disorders. In addition, she is involved in research on perinatal and genetic epidemiology, health in immigrant populations, and social inequality in health. Academically, she is an adjunct professor at the Department of Global Health and Primary Care, University of Bergen, and holds an honorary doctorate at the University of Copenhagen.

Camilla Stoltenberg

Akhmetov Valikhan Isaevich

Former Director, National Centre for Public Healthcare, Kazakhstan

Akhmetov Valikhan Isaevich graduated with honors from the Almaty State Medical University named after S.D. Asfendiyarov, specializing in Medicine. In 1998, he graduated from Kemerovo State University with a degree in Economics and Management, and was an economist. He began his career as a nurse, then as an average medical worker and a doctor at the Central Clinical Hospital in Almaty.

He worked as a leading specialist, head of department of the Center for payment for medical services, director of the National Center for Analysis and Assessment of the quality of medical services in Almaty. In 2003-2004, he was a member of the Board of Directors of the National Center for Analysis and Evaluation of the Quality of Medical Services in Almaty and head of sector at the Center for Systemic Research in the Economic Policy Department of the Presidential Administration, deputy director of the Department of Social Spending Planning in the Ministry of Economy and Budget Planning of the Republic of Kazakhstan. 

In 2006-2008, he was appointed as chairman of the Committee on Control over the Provision of Medical Services of the Ministry of Health of the Republic of Kazakhstan. He was also a leading researcher at the Institute of Healthcare Development of the Ministry of Health, advisor to the president of the National Innovation Fund, vice-president of JSC "Social Innovative Technologies". From 2008 to 2011, he was vice-rector for Research and Clinical Work, Planning and Development of S.D. Asfendiyarov KazNMU. From 2011 to 2013, he was rector of the Almaty State Institute of Advanced Medical Education, director of State Enterprise "Republican Center for Healthcare Development", chairman of the Board of Directors of Eye Diseases Research Institute JSC, and chairman of the Supervisory Board of the Eurasian Healthcare Association. In 2015, he was appointed as Chairman of the Supervisory Board of the Eurasian Healthcare Association. - Head of the Almaty branch of the Training and Clinical Center. From 2016 to 2017, he was head of the Healthcare Department of Almaty.

Since 2017 he has been an advisor to the Minister of Health on public health and on the organization of the 40th anniversary of the WHO Declaration on PSMP, professor of Management Department at the Cabinet of Ministers of Higher School of Education, and head of the National Center for Public Health.

Akhmetov Valikhan Isaevich

Abdullah Algwizani

Chief Executive Officer, Saudi Arabia Centers for Disease Control

Dr. Abdullah Algwizani joined the Saudi Center for Disease Prevention and Control from its inception as the founding chief executive in 2018. Reporting to His Excellency, the minister of Health, Dr. Algwizani is responsible for achieving the organization’s goal to protect and improve the health of the population in the Kingdom. He is passionate about supporting the development of a nation that lives longer and healthier. He envisages the success of this mission as a joint endeavor across and beyond the healthcare system.

As a published researcher with a medical background in Infectious Diseases and as a practicing consultant, Dr. Algwizani has held many key positions. He was the director of Infection Prevention and Control at King Abdullah Specialist Children’s Hospital. In addition, he is part of several national and international memberships on a wide range of committees such as; Public Health, Dengue Control, Vaccines and Biological Medicine. 

He has also represented the country at international forums, including the World Health Assembly, Global Health Security Agenda (GHSA) Steering Committee and is the Anti-Microbial Resistance Champion for the Kingdom of Saudi Arabia in the G20.

Abdullah Algwizani

Prof Aamer Ikram, SI(M)

Executive Director, National Institute of Health, Pakistan

Professor Aamer is a member NPHI director and an IANPHI Executive Board member. He is currently executive director of National Institute of Health of Pakistan. He is chair of the Board of Directors of the International Federation of Biosafety Associations (IFBA), member of Health Security Interface Group of the World Health Organization, and of the Executive Council of the International Society for Infectious Diseases. He is president of the Pakistan Biological Safety Association, and former president of the Medical Microbiology & Infectious Diseases Society.

Ikram did his fellowship and PhD in Microbiology. He has a qualified diploma in Occupational Safety Health & Environments, a diploma in Disaster Management, a certificate in Emerging Infectious Diseases from the University of Iowa and in Dual-Use Biosecurity from Bradford University. He is a fellow of the Royal College of Physicians by the Royal College of Edinburgh (FRCP), FRCPath by the Royal College of Pathologists of London, and Fellowship in Public Health from the Royal Colleges UK. He has special interest in mycobacteriology, biosafety and infection control. He published more than 300 papers, including books and chapters. He received the ‘Biosafety Heroes Award’ from IFBA.

Aamer Ikram

Sabin Nsanzimana, MD, MSc, PhD, FRCP

Director General, Rwanda Biomedical Center

Dr. Sabin NSANZIMANA is currently the director general of the Rwanda Biomedical Centre and has been working for the health sector for over 15 years with extensive experience in control of infectious diseases and research with more than 120 published scientific articles. 

He holds a Medical Degree (MD) and a Master's Degree in Clinical Epidemiology from the National University of Rwanda; a PhD in Epidemiology from Swiss Tropical and Public Health Institute,University of Basel, Switzerland. 

Dr. Sabin serves as a fellow at the African Scientific Institute (ASI), a fellow of the Royal College of Physicians of Edinburgh (FRCP Edin) and serves as assistant professor of Global Health at the University of Global Health Equity (UGHE) and teaches Epidemiology and Research Methodology at the University of Rwanda.

Dr. Sabin Nsanzimana leads all technical aspects of the COVID-19 response in Rwanda and chairs the COVID-19 national task force Scientific Advisory Group.

Sabin Nsanzimana

Markku Tervahauta, MD, PhD

Director General, Finnish Institute of Health and Welfare

Dr. Markku Tervahauta is a doctor of Medical Science, specialized in Public Health. He has a doctoral degree (PhD) in epidemiology from the University of Eastern Finland (former University of Kuopio). Dr. Tervahauta’s main working career has been in leadership positions in municipal and national public health organisations. 

Tervahauta has served as director general of the Department for Wellbeing and Services at the Ministry of Social Affairs and Health since February 2018. Before that, he worked at the local government level as director of Health and Social Services, first in the City of Lahti since 2009 and then in the City of Kuopio since 2010. He worked as chief executive of the Municipality of Leppävirta from 2005 to 2009. 

Dr. Tervahauta started as a director general of the Finnish Institute for Health and Welfare in January 2019.  At the same time he joined the IANPHI network and participated in the IANPHI Annual Meeting in Addis Ababa Ethiopia in December 2019.



Igbal Abukarig
Public Health Institute, Sudan 
Director

Paulo Buss 
Oswaldo Cruz Foundation/FIOCRUZ 
Brazil
Former President

Reinhard Burger
Robert Koch Institute, Germany
President

David Butler-Jones 
Public Health Agency, Canada
Director

Cesar Cabezas
National Institute of Health, Peru
Director

L.S. Chauhan
National Centre for Disease Control, India
Director

Rajae El Aouad 
National Institute of Hygiene, Morocco 
Former Director

Naima El Mdaghri 
Institut Pasteur du Maroc
Director General  

Mohammed Hassar 
Institute Pasteur du Maroc 
Former Director

Mauricio Hernández-Avila
IANPHI Immediate Past President 
National Institute of Public Health, Mexico former Director

Oni Idigbe 
Former Director General, Nigerian Institute of Medical Research 
Director of Research

Ilesh Jani
National Institute of Health, Mozambique
Director General

Amha Kebede 
Ethiopian Public Health Institute
Director

Jeffrey P. Koplan 
Senior Advisor, IANPHI 
Vice President for Global Health, Emory University

Justin McCracken 
Health Protection Agency, United Kingdom 
Former Chief Executive

Tsehaynesh Messele 
Ethiopian Health and Nutrition Research Institute 
Former Director General

Pekka Puska
Former IANPHI President 
Former Director General, National 
Institute for Health and Welfare, Finland

Mahmudur Rahman 
Institute of Epidemiology, Disease Control and Research, Bangladesh
Director

Amabelia Rodrigues 
National Institute of Public Health, Guinea Bissau 
Former President

Mario Henry Rodriguez 
National Institute of Public Health, Mexico 
Former General Director

Pathom Sawanpanyalert 
National Institute of Health 
Former Director General

Barry Schoub 
National Institute of Communicable Diseases, South Africa 
Former Executive Director

Marc Sprenger 
Director, European Centre for Disease Prevention and Control 
Netherlands

Geir Stene-Larsen 
Norwegian Institute of Public Health 
Director General

Gregory Taylor 
Public Health Agency of Canada 
Chief Public Health Officer

Jaroslav Volf 
Former Director, National Institute of Public Health 
Czech Republic

Yu Wang
Centers for Disease Control, China
Director-General

Jane Wilde 
Institute of Public Health in Ireland 
Former Chief Executive